20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T15389L | Glucagon (1-29), bovine, human, porcine hydrochloride | Porcine glucagon hydrochloride,Glucagon hydrochloride | Glucocorticoid Receptor , Glucagon Receptor |
Glucagon (1-29), bovine, human, porcine hydrochloride is a peptide hormone, produced by pancreatic α-cells. It activates HNF4α and increases HNF4α phosphorylation. Glucagon (1-29), bovine, human, porcine hydrochloride(Po... | |||
TP1863L | Glucagon (19-29), human acetate | Glucagon Receptor | |
Glucagon (19-29), human acetate a COOH-terminal fragment processed from glucagon, is a potent and efficient inhibitor of insulin secretion. | |||
TQ0239 | PF-06291874 | Glucagon receptor antagonists-4 | Glucagon Receptor |
PF-06291874 (Glucagon receptor antagonists-4) (Glucagon receptor antagonists-4) is a highly effective and orally active antagonist of the glucagon receptor. | |||
T15389 | Glucagon (1-29), bovine, human, porcine | Porcine glucagon,Glucagon | Others |
Glucagon is a peptide hormone, produced by pancreatic α-cells. Glucagon reduces the activity of HNF-4. Glucagon stimulates gluconeogenesis. Glucagon enhances HNF4α phosphorylation. | |||
T36638 | [Des-His1,Glu9]-Glucagon amide TFA | [Des-His1,Glu9]-Glucagon amide TFA | |
[Des-His1,Glu9]-Glucagon amide TFA is a potent peptide antagonist targeting the glucagon receptor, featuring a pA2 value of 7.2. It holds potential utility in diabetes pathogenesis research[1]. | |||
TP2033 | [Des-His1,Glu9]-Glucagon amide | des-His1-[Glu9]-Glucagon (1-29) amide | |
Glucagon receptor antagonist (pA2 = 7.2 for inhibition of glucagon-induced adenylyl cyclase activation in rat liver membranes); displays no agonist activity. Enhances glucose-stimulated pancreatic insulin release in vitr... | |||
T37223 | Glucagon Receptor Antagonist I | ||
Glucagon receptor antagonist I is a competitive antagonist of the glucagon receptor (GCGR; IC50 = 181 nM). It blocks glucagon-induced glycogenolysis in primary human hepatocytes and isolated liver. Glucagon receptor anta... | |||
T78059 | Glucagon (Human) | Hyperglycemic-glycogenolytic factor,Glukagon | Others |
Glucagon significantly impacts protein and amino acid metabolism. It hinders the integration of amino acids into the proteins of the liver, muscle, and pancreas, augmenting nitrogen excretion and stimulating hepatic urea... | |||
T36580 | Glucagon Receptor Antagonist Inactive Control | ||
Glucagon Receptor Antagonist Inactive Control is a Glucagon receptor antagonist that can be used in related research in the field of life sciences. Its product number is T36580 and CAS number is 362482-00-6. | |||
T11416 | Glucagon receptor antagonists-5 | Others | |
Glucagon receptor antagonists-5 is an orally bioavailable indazole-based glucagon receptor antagonist (Ki: 32 nM). It has potential for the treatment of type 2 diabetes mellitus (T2DM). | |||
TP1863 | Glucagon (19-29), human | ||
Glucagon is a 29-amino-acid peptide hormone liberated in the alpha cells of the islets of Langerhans. Glucagon-producing alpha cells represent one of the earliest populations of detectable islet cells in the developing e... | |||
T11415 | Glucagon receptor antagonists-3 | Others | |
Glucagon receptor antagonist -3 is a highly effective glucagon receptor antagonist. | |||
T11414 | Glucagon receptor antagonists-2 | Others | |
Glucagon receptor antagonist -2 is a highly effective glucagon receptor antagonist. | |||
T11413 | Glucagon receptor antagonists-1 | Others | |
Glucagon receptor antagonist -1 is a highly effective glucagon receptor antagonist. | |||
TP1487 | Glucagon-Like Peptide (GLP) II, human | ||
Glucagon-like peptide 2 (GLP-2) is a recently identified intestinal epithelium-specific growth factor that has been shown to reduce the severity of inflammatory disorders of the intestine in rodent models. Currently Gluc... | |||
T3984 | GLP-1(7-36), amide | MKC 253,Human GLP-1-(7-36)-amide,Glucagon-like Peptide 1 (7-36) amide,Glucagon-Like Peptide (GLP) I (7-36), amide, human,GLP-1(7-36),GLP-1-(7-36)-amide | Glucagon Receptor |
GLP-1(7-36), amide (MKC 253) is a peptide hormone released from intestinal L-cells upon nutrient consumption. It binds the GLP-1 receptor in the pancreas and displays various antidiabetic effects by potentiating glucose-... | |||
TP1148L | Glucagon-like peptide 1 (1-37), human acetate | Glucagon Receptor | |
Glucagon-like peptide 1 (1-37), human acetate is a highly potent the GLP-1 receptor agonist. | |||
TP1148 | Glucagon-like peptide 1 (1-37), human | HuGLP-1 | |
Glucagon-like peptide 1 (1-37), human is a highly potent agonist of the GLP-1 receptor.Pancreatic hormone synthesized by post-translational processing of proglucagon. Unlike truncated forms of GLP-1, it has no effect on ... | |||
T82306 | Glucagon (22-29) | ||
Glucagon (22-29) acts as a partial agonist of Glucagon (19–29) and independently inhibits the calcium (Ca2+) pump in liver plasma membranes without activating adenylate cyclase [1] [2]. | |||
TP1147 | Glucagon-like peptide 1 (1-37), human TFA | HuGLP-1 TFA | |
Glucagon-like peptide 1 (1-37), human (TFA) is a highly potent agonist of the GLP-1 receptor, it is a kind of pancreatic hormone synthesized by post-translational processing of proglucagon. |